Humanized immunodeficient mice offer a versatile model for the assessment of human-based immunotherapies. Our team at Biocytogen independently designed and generated the severely immunodeficient B-NDG mouse model (NOD.CB17-Prkdcscid Il2rgtm1Bcgen/Bcgen). B-NDG mice lack mature T cells, B cells, functional NK cells, and display cytokine signaling deficiencies. These collective properties render B-NDG mice with the highest degree of immunodeficiency, making B-NDG mice most suitable for engraftment and growth of human hematopoietic stem cells (HSCs), peripheral blood mononuclear cells (PBMCs), and human tumor cells/tissues. Based on the B-NDG mice, Biocytogen has also developed a series of second-generation mice tailored for different applications.
on this page
CB17/lcr-PrkdcscidFcgr4tm1Bcgen/Bcgen • 111654
CB17/lcr-PrkdcscidFcgr4tm2(FCGR3A)Bcgen/Bcgen • 113688